This page includes the latest FDA filings for Nova Laboratories L T D. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| Registration Number | 3005813646 |
| FEI Number | 3000323524 |
| Name | NOVA LABORATORIES LIMITED |
| Owner & Operator | Nova Laboratories Limited |
| Contact Address | Martin House Gloucester Crescent Wigston GB-LEC Leicestershire LE18 4YL GB |
| Official Correspondent |
|
| US Agent |
|
| Registration Status | 1 |
| Initial Importer | N |
| Registration Expiration | 2020-04-25 |
| Registration Address | Martin House Gloucester Crescent Wigston Leicestershire, LE18 4YL GB |
| Establishment Type | Manufacture Medical Device for Another Party (Contract Manufacturer) |
Device Company | Device | Date |
|---|---|---|
| Nova Laboratories, Ltd, Rare Disease Therapeutics, Inc. | Prescription Medication | 2025-09-10 |
| Nova Laboratories, Ltd, Rare Disease Therapeutics, Inc. | Prescription Medication | 2025-08-22 |
| Nova Laboratories, Ltd., Rare Disease Therapeutics, Inc., Nova Laboratories, Ltd | Prescription Medication | 2025-08-22 |
| Nova Laboratories, Ltd, Rare Disease Therapeutics, Inc. | Prescription Medication | 2025-06-13 |
| Nova Laboratories, Ltd., Rare Disease Therapeutics, Inc., Nova Laboratories, Ltd | Prescription Medication | 2025-01-05 |
| Nova Laboratories, Ltd., Rare Disease Therapeutics, Inc., Nova Laboratories, Ltd | Prescription Medication | 2024-10-30 |
| Nova Laboratories, Ltd, Rare Disease Therapeutics, Inc. | Prescription Medication | 2024-10-27 |
| Nova Laboratories, Ltd., Rare Disease Therapeutics, Inc., Nova Laboratories, Ltd | Prescription Medication | 2024-10-23 |
| Nova Laboratories, Ltd, Rare Disease Therapeutics, Inc. | Prescription Medication | 2024-07-11 |
| Nova Laboratories, Ltd, Rare Disease Therapeutics, Inc. | Prescription Medication | 2024-05-02 |
| Spark Therapeutics, Inc., BioReliance Corporation, Pharmaceutical Product Development, Inc. (PPD), Absorption Systems, Eurofins (Lancaster Laboratories), Intertek Pharmaceutical Services, Nova Laboratories Ltd, Catalent Pharma Solutions, Hologic Ltd Tepnel Pharma | Prescription Medication | 2024-04-18 |
| Nova Laboratories, Ltd., Rare Disease Therapeutics, Inc., Nova Laboratories, Ltd | Prescription Medication | 2024-04-10 |
| Nova Laboratories, Ltd, Rare Disease Therapeutics, Inc. | Prescription Medication | 2022-10-12 |
| Spark Therapeutics, Inc., BioReliance Corporation, Pharmaceutical Product Development, Inc. (PPD), Absorption Systems, Eurofins (Lancaster Laboratories), Intertek Pharmaceutical Services, Nova Laboratories Ltd, Catalent Pharma Solutions, Hologic Ltd Tepnel Pharma | Prescription Medication | 2022-06-24 |
| Nova Laboratories, Ltd, Rare Disease Therapeutics, Inc. | Prescription Medication | 2020-04-15 |
| Spark Therapeutics, Inc., BioReliance Corporation, Pharmaceutical Product Development, Inc. (PPD), Absorption Systems, Eurofins (Lancaster Laboratories), Intertek Pharmaceutical Services, Nova Laboratories Ltd, Catalent Pharma Solutions, Hologic Ltd Tepnel Pharma | Prescription Medication | 2020-01-15 |
| Spark Therapeutics, Inc., BioReliance Corporation, Pharmaceutical Product Development, Inc. (PPD), Absorption Systems, Eurofins (Lancaster Laboratories), Intertek Pharmaceutical Services, Nova Laboratories Ltd, Catalent Pharma Solutions, Hologic Ltd Tepnel Pharma | Prescription Medication | 2019-09-25 |
| Spark Therapeutics, Inc., BioReliance Corporation, Pharmaceutical Product Development, Inc. (PPD), Absorption Systems, Eurofins (Lancaster Laboratories), Intertek Pharmaceutical Services, Nova Laboratories Ltd, Catalent Pharma Solutions, Hologic Ltd Tepnel Pharma | Prescription Medication | 2019-06-26 |
| Nova Laboratories, Ltd, Rare Disease Therapeutics, Inc. | Prescription Medication | 2019-04-10 |
NOVA LABORATORIES LIMITED | Magtrace | 2018-09-27 |
| Nova Laboratories, Ltd | PURIXAN | 2014-04-28 |
| NCAGE Code | KA249 | NOVA LABORATORIES LTD |
| CAGE Code | KA249 | NOVA LABORATORIES LTD |